Artificial Intelligence (AI) in Drug Discovery Market Report To 2031
Global AI in Drug Discovery market was valued at US$ xx million in 2021 and is projected to reach at a market value of US$ xx million by 2031.
Click here to Get Complete Synopsis of the Report @https://www.visiongain.com/report/ai-in-drug-discovery-market-2021/
COVID-19 Impact on Global AI in Drug Discovery Market
The impact of COVID-19 pandemic is there on almost all the sectors and assessing its impact on the market would be uncertain as there is no knowledge about how long this pandemic stay would. Visiongain believes that considering all the factors there can be four scenarios in which the global market can react to the current crisis and that can be ‘V’ shaped recovery, ‘U’ shaped recovery, ‘L’ shaped recovery and ‘W’ shaped recovery. The functioning of the AI in Drug Discovery was regular during the pandemic situation as there was rising demand for novel drugs for the treatment of critical diseases. In addition, the clinical progress of various drugs also continued with the use of AI but with new obstacles caused due to the pandemic and its effects. Many global companies reported challenges in clinical trial execution, including patient recruitment, enrolment, data collection and/or follow-up. In addition, managing and reacting to the ongoing public health crisis caused by COVID-19 has become the priority for many policymakers, regulators, and public sector payors. Thus, this could result in a delay for drug candidates outside of the COVID-19 space.
How the Global AI in Drug Discovery Market report helps you
In summary, our 1220+ page report provides you with the following knowledge:
Download a Sample Report with Table of Contents and Figures by clicking here @https://www.visiongain.com/report/ai-in-drug-discovery-market-2021/
• Revenue forecasts to 2031 for Global AI in Drug Discovery Market, with forecasts for Technology, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for Global AI in Drug Discovery Market, with forecasts for Application, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for Global AI in Drug Discovery Market, with forecasts for Therapeutic Area, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for Global AI in Drug Discovery Market, with forecasts for End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 20 key national markets – See forecasts for the AI in Drug Discovery market in North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the major companies involved in the Global AI in Drug Discovery Market. Some of the company’s profiled in this report include IBM Corporation, Exscientia, GNS Healthcare, DeepMind, Benevolent AI, BioSymetrics, Euretos, BERG LLC, Atomwise, Inc. and others.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:
Address: Airport House, Purley Way, Surrey, London, CR0 0XZ United Kingdom
Name : Sara Peerun
Research Insight: https://www.visiongain.com/report/ai-in-drug-discovery-market-2021/
Visiongain is one of the fastest-growing and most innovative independent market research company in London, the company comprises over 400+ analysts and consultants, adding more than 1400 market research reports to its vast database each year. These reports offer in-depth analysis on 18 industries worldwide.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence (AI) in Drug Discovery Market Report To 2031 here
News-ID: 2280274 • Views: 364
More Releases from Visiongain Ltd
Hydrogen Purification Technologies Market Forecast Report Up to 2031
Visiongain has launched a new report Hydrogen Purification Technologies Market Report 2021-2031: Forecasts by Purity Level (Pure Hydrogen, High Pure Hydrogen, Ultra Pure Hydrogen), by Technology (Pressure Swing Absorption (PSA), Membrane Technology, Electrochemical Purification Technology, Cryogenic Technology, Getter Technology, Palladium Technology, Other H2 Purification Technology), by Application (Refinery, Ammonia Production, Transport, Methanol Production, Other Applications) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Hydrogen Purification Companies AND
Veterinary Anaesthesia Equipment Market Report Up to 2031
Visiongain has published a new report on Veterinary Anaesthesia Equipment Market Report 2021-2031: Forecasts by Animal Type, By End Use, By Product (Complete Anesthesia Machines, Ventilators, Accessories). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Global Veterinary Anaesthesia Equipment market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx
Ventricular Assist Device Market Report Up tp 2031
Visiongain has published a new report on Ventricular Assist Device Market Report 2021-2031: Forecasts by Product (LVAD, RVAD, BiVAD, TAH), By Type of Flow (Pulsatile, Continuous), By Design, By Application. PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. GlobalVentricular Assist Device market was valued at US$ xx billion in 2020 and is projected to reach at a market value of
Global Port and Marine Security Market Report Up to 2030
Visiongain has launched a new report Port and Marine Security Market Report 2020-2030: Forecasts by Vertical (Airport, Marine Port), by Technology (Surveillance Systems, Physical Access Control Systems, Screening and Scanning Systems, Perimeter Intrusion Detection Systems, Network Access Control and Security, Real Time Location Systems), Services (Facility Asset Management, System Integration, Training and Consulting) with Regional and National Market Analysis and Financial Analysis of Leading Companies. Global port and maritime security market
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning